...
首页> 外文期刊>International Journal of Pharmaceutics >Evaluation of in vitro and in vivo antitumor effects of gambogic acid-loaded layer-by-layer self-assembled micelles
【24h】

Evaluation of in vitro and in vivo antitumor effects of gambogic acid-loaded layer-by-layer self-assembled micelles

机译:对体外和体内抗肿瘤作用的评价甘草酸负载的逐层自组装胶束的抗肿瘤作用

获取原文
获取原文并翻译 | 示例
           

摘要

This study aimed to develop a novel type of multilayer micelle using protamine (PRM) and hyaluronic acid (HA) for the delivery of gambogic acid (GA). GA-loaded micelles (GA-M) were simply and rapidly prepared using lecithin/solutol HS15 using a film-dispersion method. PRM and HA were added in sequence to form layer-bylayer self-assembled micelles (HA-PRM-GA-M), in which particle size, zeta potential, particle morphology, drug loading, encapsulation efficiency, and in vitro release were investigated. Surface charge reversal demonstrated that rapid HA detachment exposed PRM, leading to activation of a "proton sponge" effect in the hyaluronidase (HAase)-rich tumor microenvironment. Compared with coumarin 6-loaded micelles (C6-M), more efficient intracellular trafficking was observed for HA-PRM-C6-M, which is associated with the endosomal/lysosomal escaping ability of the exposed PRM. In vivo imaging showed increased enrichment of near infrared fluorescent dye (DIR)-loaded HA-PRM-DIR-M at the tumor site, suggesting that HA enhanced the active tumor targeting of GA. Furthermore, HA-PRM-GA-M showed the stronger antitumor activity than GA and GA-M against human lung adenocarcinoma (A549) tumor xenografts in nude mice. In summary, our findings show the potential of HAPRM- GA-M as a novel intravenous drug carrier for the treatment of lung cancer.
机译:本研究旨在使用protamine(PRM)和透明质酸(HA)来开发一种新型多层胶束,用于递送甘胺酸(GA)。使用薄膜分散方法,使用卵磷脂/索丁醇HS15简单且快速制备GA加载的胶束(GA-M)。依次加入PRM和HA以形成层旁白的自组装胶束(HA-PRM-GA-M),其中研究了粒度,Zeta电位,颗粒形态,药物负载,包封效率和体外释放。表面电荷反转证明了快速的HA脱离暴露PRM,导致透明质酸酶(HAase) - 中间肿瘤微环境中的“质子海绵”效应。与香豆素6加载的胶束(C6-M)相比,对HA-PRM-C6-M的较高效率的细胞内运输,其与暴露的PRM的内体/溶酶体逸出能力相关。体内成像表明,在肿瘤部位的近红外荧光染料(DIR)的近红外荧光染料(DIR)增加了富集的富集,表明HA增强了GA的活性肿瘤靶向。此外,HA-PRM-GA-M表现出比GA和GA-M对抗人肺腺癌(A549)裸鼠肿瘤异种移植物的抗肿瘤活性更强。总之,我们的研究结果表明HAPRM-GA-M作为一种用于治疗肺癌的新型静脉内药物载体的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号